 Wendy Tzou
Concepts (309)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catheter Ablation | 68 | 2023 | 286 | 15.980 |
Why?
| | Tachycardia, Ventricular | 43 | 2023 | 151 | 12.610 |
Why?
| | Atrial Fibrillation | 17 | 2023 | 338 | 5.190 |
Why?
| | Cardiomyopathies | 17 | 2022 | 298 | 4.100 |
Why?
| | Arrhythmias, Cardiac | 22 | 2023 | 277 | 3.210 |
Why?
| | Cicatrix | 6 | 2022 | 53 | 2.460 |
Why?
| | Electrophysiologic Techniques, Cardiac | 15 | 2021 | 71 | 2.400 |
Why?
| | Transcatheter Aortic Valve Replacement | 5 | 2023 | 151 | 2.280 |
Why?
| | Electrocardiography | 18 | 2023 | 555 | 1.850 |
Why?
| | Heart Diseases | 6 | 2023 | 340 | 1.790 |
Why?
| | Pacemaker, Artificial | 5 | 2023 | 105 | 1.710 |
Why?
| | Defibrillators, Implantable | 14 | 2023 | 299 | 1.680 |
Why?
| | Ventricular Premature Complexes | 6 | 2022 | 23 | 1.640 |
Why?
| | Heart Ventricles | 11 | 2022 | 725 | 1.560 |
Why?
| | Pericardium | 9 | 2021 | 50 | 1.550 |
Why?
| | Atrioventricular Block | 2 | 2021 | 33 | 1.470 |
Why?
| | Amiodarone | 2 | 2021 | 24 | 1.390 |
Why?
| | Pulmonary Veins | 3 | 2019 | 84 | 1.350 |
Why?
| | Cardiac Pacing, Artificial | 5 | 2023 | 85 | 1.340 |
Why?
| | Aortic Valve Stenosis | 4 | 2023 | 296 | 1.310 |
Why?
| | Heart Failure | 6 | 2023 | 1967 | 1.150 |
Why?
| | Heart Conduction System | 10 | 2023 | 81 | 1.110 |
Why?
| | Myocardium | 12 | 2023 | 965 | 1.050 |
Why?
| | Cardiac Electrophysiology | 6 | 2021 | 11 | 1.000 |
Why?
| | Echocardiography | 6 | 2021 | 556 | 0.980 |
Why?
| | Treatment Outcome | 34 | 2023 | 9319 | 0.950 |
Why?
| | Electric Countershock | 6 | 2023 | 110 | 0.950 |
Why?
| | Death, Sudden, Cardiac | 5 | 2023 | 166 | 0.940 |
Why?
| | Atrial Appendage | 2 | 2020 | 8 | 0.930 |
Why?
| | Muscular Dystrophies | 1 | 2023 | 36 | 0.910 |
Why?
| | Humans | 103 | 2023 | 118257 | 0.910 |
Why?
| | Recurrence | 15 | 2022 | 971 | 0.900 |
Why?
| | Electrocardiography, Ambulatory | 3 | 2019 | 53 | 0.900 |
Why?
| | Endocardium | 7 | 2022 | 31 | 0.890 |
Why?
| | Electrodes | 6 | 2022 | 89 | 0.860 |
Why?
| | Myocarditis | 1 | 2023 | 94 | 0.850 |
Why?
| | Carotid Arteries | 4 | 2006 | 184 | 0.810 |
Why?
| | Postoperative Complications | 7 | 2019 | 2230 | 0.800 |
Why?
| | Neuromuscular Diseases | 1 | 2021 | 90 | 0.740 |
Why?
| | Surgery, Computer-Assisted | 1 | 2021 | 69 | 0.740 |
Why?
| | Esophagus | 3 | 2023 | 237 | 0.730 |
Why?
| | Ablation Techniques | 2 | 2019 | 29 | 0.720 |
Why?
| | Cardiology | 5 | 2020 | 272 | 0.710 |
Why?
| | Anti-Arrhythmia Agents | 8 | 2023 | 113 | 0.700 |
Why?
| | Heart Atria | 5 | 2023 | 112 | 0.700 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2022 | 344 | 0.690 |
Why?
| | Consensus | 9 | 2020 | 533 | 0.660 |
Why?
| | Tunica Intima | 4 | 2008 | 77 | 0.640 |
Why?
| | Heart Rate | 6 | 2019 | 729 | 0.610 |
Why?
| | Pericardial Effusion | 1 | 2017 | 18 | 0.600 |
Why?
| | Action Potentials | 7 | 2019 | 420 | 0.600 |
Why?
| | Heart Block | 3 | 2023 | 37 | 0.590 |
Why?
| | Epicardial Mapping | 5 | 2022 | 5 | 0.570 |
Why?
| | Cardiac Resynchronization Therapy | 1 | 2017 | 42 | 0.560 |
Why?
| | Therapeutic Irrigation | 4 | 2020 | 67 | 0.550 |
Why?
| | Risk Factors | 17 | 2023 | 8958 | 0.540 |
Why?
| | Cardiac Catheters | 4 | 2020 | 14 | 0.540 |
Why?
| | Aged | 33 | 2023 | 19594 | 0.530 |
Why?
| | Venous Thrombosis | 1 | 2017 | 145 | 0.520 |
Why?
| | Middle Aged | 40 | 2020 | 27511 | 0.510 |
Why?
| | Arthritis, Rheumatoid | 1 | 2023 | 990 | 0.510 |
Why?
| | Body Temperature | 3 | 2015 | 214 | 0.500 |
Why?
| | Catheters | 4 | 2022 | 61 | 0.490 |
Why?
| | Multimodal Imaging | 3 | 2019 | 100 | 0.480 |
Why?
| | Risk Assessment | 13 | 2020 | 3043 | 0.480 |
Why?
| | Societies, Medical | 5 | 2020 | 701 | 0.460 |
Why?
| | Bundle-Branch Block | 3 | 2023 | 27 | 0.460 |
Why?
| | Intraoperative Neurophysiological Monitoring | 1 | 2013 | 16 | 0.460 |
Why?
| | Male | 49 | 2021 | 57476 | 0.440 |
Why?
| | Aortic Valve | 4 | 2023 | 402 | 0.420 |
Why?
| | Predictive Value of Tests | 8 | 2019 | 1857 | 0.410 |
Why?
| | Heart | 6 | 2022 | 630 | 0.410 |
Why?
| | Time Factors | 12 | 2021 | 6368 | 0.410 |
Why?
| | Swine | 7 | 2023 | 719 | 0.400 |
Why?
| | Female | 47 | 2023 | 61262 | 0.400 |
Why?
| | Cattle | 12 | 2020 | 974 | 0.360 |
Why?
| | Carotid Artery Diseases | 2 | 2008 | 58 | 0.360 |
Why?
| | Tunica Media | 3 | 2008 | 35 | 0.360 |
Why?
| | Atrioventricular Node | 1 | 2009 | 13 | 0.360 |
Why?
| | Retrospective Studies | 23 | 2023 | 12929 | 0.350 |
Why?
| | Incidence | 6 | 2021 | 2413 | 0.350 |
Why?
| | Ventricular Function, Left | 5 | 2021 | 468 | 0.340 |
Why?
| | Tachycardia, Supraventricular | 1 | 2009 | 40 | 0.340 |
Why?
| | Stroke Volume | 8 | 2021 | 513 | 0.330 |
Why?
| | Cardiac Surgical Procedures | 3 | 2021 | 458 | 0.330 |
Why?
| | Ultrasonography | 3 | 2008 | 714 | 0.330 |
Why?
| | Decision Support Techniques | 2 | 2022 | 364 | 0.310 |
Why?
| | Survival Rate | 5 | 2019 | 1716 | 0.310 |
Why?
| | Reoperation | 3 | 2019 | 557 | 0.300 |
Why?
| | Cardiac Catheterization | 1 | 2011 | 541 | 0.300 |
Why?
| | Body Surface Potential Mapping | 5 | 2019 | 7 | 0.300 |
Why?
| | Hypercapnia | 1 | 2007 | 50 | 0.300 |
Why?
| | Coronary Circulation | 1 | 2007 | 121 | 0.290 |
Why?
| | Genetic Testing | 1 | 2009 | 388 | 0.290 |
Why?
| | Follow-Up Studies | 12 | 2021 | 4574 | 0.290 |
Why?
| | Ventricular Dysfunction, Left | 3 | 2018 | 374 | 0.280 |
Why?
| | Sarcoidosis | 2 | 2019 | 130 | 0.280 |
Why?
| | Cardiac Imaging Techniques | 2 | 2019 | 13 | 0.270 |
Why?
| | Blood Flow Velocity | 1 | 2007 | 327 | 0.270 |
Why?
| | Arteriosclerosis | 1 | 2005 | 88 | 0.260 |
Why?
| | Hot Temperature | 3 | 2023 | 333 | 0.260 |
Why?
| | Adult | 23 | 2021 | 31325 | 0.260 |
Why?
| | Coronary Vessels | 1 | 2007 | 233 | 0.260 |
Why?
| | Bundle of His | 2 | 2023 | 16 | 0.260 |
Why?
| | Point-of-Care Systems | 1 | 2006 | 146 | 0.260 |
Why?
| | Accessory Atrioventricular Bundle | 2 | 2021 | 11 | 0.250 |
Why?
| | Reproducibility of Results | 6 | 2019 | 2855 | 0.250 |
Why?
| | Liposomes | 2 | 2023 | 150 | 0.240 |
Why?
| | Cholesterol | 1 | 2005 | 375 | 0.240 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2020 | 1237 | 0.230 |
Why?
| | Biophysical Phenomena | 2 | 2020 | 64 | 0.230 |
Why?
| | Temperature | 2 | 2023 | 621 | 0.220 |
Why?
| | Animals | 17 | 2023 | 33152 | 0.220 |
Why?
| | Thromboembolism | 1 | 2023 | 99 | 0.210 |
Why?
| | Philadelphia | 3 | 2019 | 47 | 0.200 |
Why?
| | Pre-Excitation Syndromes | 1 | 2021 | 5 | 0.200 |
Why?
| | Arrhythmogenic Right Ventricular Dysplasia | 2 | 2012 | 29 | 0.200 |
Why?
| | Prospective Studies | 6 | 2023 | 6443 | 0.200 |
Why?
| | Glycogen Storage Disease Type IIb | 1 | 2021 | 20 | 0.200 |
Why?
| | Metabolic Syndrome | 1 | 2005 | 392 | 0.200 |
Why?
| | Skin | 1 | 2005 | 657 | 0.200 |
Why?
| | Coronary Sinus | 1 | 2020 | 7 | 0.190 |
Why?
| | Tachycardia, Atrioventricular Nodal Reentry | 1 | 2020 | 27 | 0.190 |
Why?
| | Prevalence | 5 | 2021 | 2321 | 0.180 |
Why?
| | Registries | 2 | 2021 | 1806 | 0.180 |
Why?
| | Anticoagulants | 3 | 2023 | 555 | 0.180 |
Why?
| | Prognosis | 7 | 2019 | 3424 | 0.180 |
Why?
| | Papillary Muscles | 1 | 2019 | 13 | 0.180 |
Why?
| | Tricuspid Valve Insufficiency | 1 | 2019 | 18 | 0.180 |
Why?
| | Heart-Assist Devices | 2 | 2023 | 485 | 0.180 |
Why?
| | Patient Safety | 2 | 2020 | 281 | 0.170 |
Why?
| | Aortic Valve Insufficiency | 1 | 2019 | 42 | 0.170 |
Why?
| | Colorado | 3 | 2019 | 4178 | 0.170 |
Why?
| | Multicenter Studies as Topic | 1 | 2020 | 252 | 0.170 |
Why?
| | Esophageal Fistula | 1 | 2019 | 16 | 0.170 |
Why?
| | Mitral Valve Insufficiency | 1 | 2019 | 62 | 0.170 |
Why?
| | Kaplan-Meier Estimate | 4 | 2018 | 840 | 0.170 |
Why?
| | In Vitro Techniques | 5 | 2020 | 1082 | 0.170 |
Why?
| | Heparin | 1 | 2020 | 230 | 0.160 |
Why?
| | Hypertension | 2 | 2017 | 1199 | 0.160 |
Why?
| | Fibrosis | 2 | 2018 | 480 | 0.160 |
Why?
| | Medicare | 3 | 2022 | 664 | 0.160 |
Why?
| | United States | 9 | 2022 | 12491 | 0.150 |
Why?
| | Ventricular Function, Right | 1 | 2019 | 257 | 0.150 |
Why?
| | Antihypertensive Agents | 2 | 2017 | 436 | 0.150 |
Why?
| | Materials Testing | 2 | 2016 | 359 | 0.150 |
Why?
| | Environment | 1 | 2018 | 346 | 0.140 |
Why?
| | Magnets | 1 | 2016 | 15 | 0.140 |
Why?
| | Echocardiography, Transesophageal | 1 | 2017 | 89 | 0.140 |
Why?
| | Heart Valve Prosthesis | 1 | 2018 | 125 | 0.140 |
Why?
| | Disease Management | 1 | 2020 | 566 | 0.140 |
Why?
| | Ferric Compounds | 1 | 2016 | 39 | 0.140 |
Why?
| | Heart Injuries | 1 | 2016 | 38 | 0.140 |
Why?
| | Adipose Tissue | 1 | 2020 | 595 | 0.140 |
Why?
| | Equipment Design | 4 | 2020 | 518 | 0.130 |
Why?
| | Thermography | 1 | 2015 | 12 | 0.130 |
Why?
| | Mitral Valve | 2 | 2019 | 91 | 0.130 |
Why?
| | Blood Coagulation | 1 | 2017 | 202 | 0.130 |
Why?
| | Metal Nanoparticles | 1 | 2016 | 73 | 0.130 |
Why?
| | Odds Ratio | 2 | 2010 | 993 | 0.130 |
Why?
| | Adiposity | 1 | 2020 | 508 | 0.130 |
Why?
| | Heart Transplantation | 1 | 2020 | 672 | 0.120 |
Why?
| | Feasibility Studies | 2 | 2015 | 746 | 0.120 |
Why?
| | Medical Records | 1 | 2015 | 160 | 0.120 |
Why?
| | Nanotubes, Carbon | 1 | 2014 | 44 | 0.120 |
Why?
| | Fee-for-Service Plans | 1 | 2014 | 79 | 0.120 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2013 | 37 | 0.120 |
Why?
| | Energy Transfer | 1 | 2013 | 52 | 0.110 |
Why?
| | Systole | 2 | 2019 | 168 | 0.110 |
Why?
| | Hemodynamics | 1 | 2017 | 1002 | 0.110 |
Why?
| | Primary Prevention | 1 | 2014 | 183 | 0.110 |
Why?
| | Ventricular Fibrillation | 1 | 2012 | 51 | 0.110 |
Why?
| | Heart Defects, Congenital | 1 | 2019 | 700 | 0.110 |
Why?
| | Sinus of Valsalva | 1 | 2012 | 9 | 0.110 |
Why?
| | Cohort Studies | 5 | 2021 | 5078 | 0.110 |
Why?
| | Heart Septum | 1 | 2011 | 28 | 0.100 |
Why?
| | Atrial Flutter | 1 | 2011 | 24 | 0.100 |
Why?
| | Magnetic Resonance Imaging | 3 | 2018 | 3169 | 0.100 |
Why?
| | Myocardial Ischemia | 1 | 2012 | 251 | 0.090 |
Why?
| | Nanoparticles | 1 | 2014 | 324 | 0.090 |
Why?
| | Asia | 2 | 2020 | 54 | 0.090 |
Why?
| | Latin America | 2 | 2020 | 73 | 0.090 |
Why?
| | Pressure | 1 | 2011 | 226 | 0.090 |
Why?
| | Telemetry | 1 | 2010 | 32 | 0.090 |
Why?
| | Pennsylvania | 1 | 2010 | 101 | 0.090 |
Why?
| | Brugada Syndrome | 1 | 2009 | 10 | 0.090 |
Why?
| | Genetic Diseases, Inborn | 1 | 2009 | 37 | 0.090 |
Why?
| | Heart Valve Diseases | 1 | 2011 | 136 | 0.090 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2433 | 0.090 |
Why?
| | Logistic Models | 2 | 2014 | 1896 | 0.080 |
Why?
| | Patient Discharge | 1 | 2015 | 791 | 0.080 |
Why?
| | Reference Values | 2 | 2010 | 770 | 0.080 |
Why?
| | Pharmacogenetics | 1 | 2009 | 149 | 0.080 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2011 | 189 | 0.080 |
Why?
| | Age Factors | 2 | 2018 | 2990 | 0.080 |
Why?
| | Office Visits | 1 | 2008 | 83 | 0.080 |
Why?
| | Sensitivity and Specificity | 3 | 2008 | 1787 | 0.080 |
Why?
| | Severity of Illness Index | 3 | 2018 | 2659 | 0.080 |
Why?
| | Blood Gas Analysis | 1 | 2007 | 69 | 0.070 |
Why?
| | Coronary Artery Disease | 1 | 2013 | 648 | 0.070 |
Why?
| | Comorbidity | 2 | 2017 | 1516 | 0.070 |
Why?
| | Miniaturization | 1 | 2006 | 24 | 0.070 |
Why?
| | Proportional Hazards Models | 1 | 2010 | 1124 | 0.070 |
Why?
| | Signal Processing, Computer-Assisted | 2 | 2021 | 140 | 0.070 |
Why?
| | Pilot Projects | 2 | 2021 | 1405 | 0.070 |
Why?
| | Genetic Predisposition to Disease | 2 | 2018 | 2262 | 0.070 |
Why?
| | Professional Competence | 1 | 2006 | 91 | 0.070 |
Why?
| | Waist-Hip Ratio | 1 | 2005 | 31 | 0.070 |
Why?
| | Artificial Intelligence | 2 | 2023 | 137 | 0.070 |
Why?
| | Aged, 80 and over | 4 | 2018 | 6541 | 0.070 |
Why?
| | Pattern Recognition, Automated | 1 | 2006 | 75 | 0.070 |
Why?
| | Myocardial Contraction | 1 | 2007 | 338 | 0.070 |
Why?
| | Carotid Stenosis | 1 | 2006 | 75 | 0.070 |
Why?
| | Blood Pressure | 2 | 2017 | 1656 | 0.060 |
Why?
| | Ultrasonography, Doppler | 1 | 2005 | 104 | 0.060 |
Why?
| | Lipoproteins | 1 | 2005 | 163 | 0.060 |
Why?
| | Confidence Intervals | 1 | 2005 | 324 | 0.060 |
Why?
| | Age Distribution | 1 | 2005 | 358 | 0.060 |
Why?
| | Sex Distribution | 1 | 2005 | 347 | 0.060 |
Why?
| | ROC Curve | 2 | 2018 | 470 | 0.060 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2006 | 220 | 0.060 |
Why?
| | Sternotomy | 1 | 2023 | 11 | 0.060 |
Why?
| | Physician-Patient Relations | 1 | 2008 | 484 | 0.060 |
Why?
| | Magnetic Resonance Imaging, Cine | 2 | 2016 | 154 | 0.060 |
Why?
| | Triglycerides | 1 | 2005 | 515 | 0.060 |
Why?
| | Adolescent | 5 | 2021 | 18364 | 0.060 |
Why?
| | Protamines | 1 | 2023 | 5 | 0.060 |
Why?
| | Linear Models | 1 | 2005 | 817 | 0.050 |
Why?
| | Diagnosis, Differential | 2 | 2020 | 1379 | 0.050 |
Why?
| | Survival Analysis | 2 | 2018 | 1262 | 0.050 |
Why?
| | Sex Factors | 2 | 2018 | 1765 | 0.050 |
Why?
| | Atherosclerosis | 1 | 2006 | 345 | 0.050 |
Why?
| | Databases, Factual | 2 | 2018 | 1196 | 0.050 |
Why?
| | Chlorides | 1 | 2022 | 137 | 0.050 |
Why?
| | Factor Xa Inhibitors | 1 | 2023 | 138 | 0.050 |
Why?
| | Doxorubicin | 1 | 2023 | 301 | 0.050 |
Why?
| | Multivariate Analysis | 1 | 2005 | 1469 | 0.050 |
Why?
| | Chi-Square Distribution | 2 | 2013 | 524 | 0.050 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2021 | 24 | 0.050 |
Why?
| | Bradycardia | 1 | 2021 | 49 | 0.050 |
Why?
| | Vagus Nerve | 1 | 2021 | 80 | 0.050 |
Why?
| | Rivaroxaban | 1 | 2023 | 208 | 0.050 |
Why?
| | Young Adult | 4 | 2021 | 10731 | 0.050 |
Why?
| | DNA Mutational Analysis | 1 | 2021 | 379 | 0.050 |
Why?
| | Warfarin | 1 | 2020 | 139 | 0.040 |
Why?
| | Antithrombins | 1 | 2020 | 51 | 0.040 |
Why?
| | Tricuspid Valve | 1 | 2019 | 23 | 0.040 |
Why?
| | Operative Time | 1 | 2020 | 114 | 0.040 |
Why?
| | Practice Patterns, Physicians' | 1 | 2008 | 1197 | 0.040 |
Why?
| | Europe | 1 | 2020 | 355 | 0.040 |
Why?
| | Morbidity | 1 | 2020 | 293 | 0.040 |
Why?
| | Disease Progression | 2 | 2019 | 2477 | 0.040 |
Why?
| | Patient Participation | 1 | 2022 | 368 | 0.040 |
Why?
| | Sus scrofa | 1 | 2018 | 48 | 0.040 |
Why?
| | Decision Trees | 1 | 2018 | 83 | 0.040 |
Why?
| | Necrosis | 1 | 2019 | 230 | 0.040 |
Why?
| | International Cooperation | 1 | 2019 | 174 | 0.040 |
Why?
| | Hemorrhage | 1 | 2023 | 606 | 0.040 |
Why?
| | Longitudinal Studies | 1 | 2005 | 2491 | 0.040 |
Why?
| | Electric Impedance | 1 | 2018 | 99 | 0.040 |
Why?
| | Diffusion of Innovation | 1 | 2018 | 98 | 0.040 |
Why?
| | Body Mass Index | 1 | 2005 | 2074 | 0.040 |
Why?
| | Italy | 1 | 2017 | 90 | 0.040 |
Why?
| | Advisory Committees | 1 | 2019 | 212 | 0.040 |
Why?
| | Thermal Conductivity | 1 | 2016 | 5 | 0.040 |
Why?
| | Prosthesis Fitting | 1 | 2016 | 14 | 0.040 |
Why?
| | Blood Glucose | 1 | 2005 | 1936 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2016 | 3676 | 0.030 |
Why?
| | Decision Making | 1 | 2022 | 806 | 0.030 |
Why?
| | Models, Animal | 1 | 2017 | 349 | 0.030 |
Why?
| | Biomarkers | 1 | 2005 | 3568 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2016 | 179 | 0.030 |
Why?
| | Hospitals, Low-Volume | 1 | 2015 | 23 | 0.030 |
Why?
| | Hospitals, High-Volume | 1 | 2015 | 42 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 277 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2017 | 551 | 0.030 |
Why?
| | International Classification of Diseases | 1 | 2015 | 121 | 0.030 |
Why?
| | Case-Control Studies | 2 | 2012 | 3156 | 0.030 |
Why?
| | Friction | 1 | 2013 | 14 | 0.030 |
Why?
| | DNA | 1 | 2021 | 1385 | 0.030 |
Why?
| | Czech Republic | 1 | 2013 | 3 | 0.030 |
Why?
| | Elective Surgical Procedures | 1 | 2015 | 159 | 0.030 |
Why?
| | Health Care Costs | 1 | 2017 | 390 | 0.030 |
Why?
| | Hospital Mortality | 1 | 2017 | 811 | 0.030 |
Why?
| | Evidence-Based Medicine | 1 | 2017 | 690 | 0.030 |
Why?
| | Motion | 1 | 2013 | 95 | 0.030 |
Why?
| | Quality of Life | 1 | 2023 | 2355 | 0.030 |
Why?
| | Surface Properties | 1 | 2013 | 397 | 0.030 |
Why?
| | Algorithms | 2 | 2012 | 1522 | 0.030 |
Why?
| | Veins | 1 | 2012 | 59 | 0.030 |
Why?
| | Quality Improvement | 1 | 2019 | 962 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2014 | 1163 | 0.020 |
Why?
| | Angiography | 1 | 2011 | 185 | 0.020 |
Why?
| | Secondary Prevention | 1 | 2012 | 227 | 0.020 |
Why?
| | Mutation | 1 | 2021 | 3435 | 0.020 |
Why?
| | Coronary Angiography | 1 | 2012 | 311 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 2937 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1288 | 0.020 |
Why?
| | Patient Readmission | 1 | 2014 | 631 | 0.020 |
Why?
| | Models, Biological | 1 | 2016 | 1701 | 0.020 |
Why?
| | Wisconsin | 1 | 2008 | 91 | 0.020 |
Why?
| | Physicians' Offices | 1 | 2006 | 16 | 0.020 |
Why?
| | Observer Variation | 1 | 2006 | 306 | 0.020 |
Why?
| | Image Enhancement | 1 | 2006 | 181 | 0.020 |
Why?
| | Motivation | 1 | 2008 | 502 | 0.010 |
Why?
| | Population Surveillance | 1 | 2006 | 413 | 0.010 |
Why?
| | Health Behavior | 1 | 2008 | 714 | 0.010 |
Why?
| | Family Practice | 1 | 2006 | 433 | 0.010 |
Why?
| | Child | 1 | 2021 | 19033 | 0.010 |
Why?
|
|
Tzou's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|